People · Operator
Named in public records as an officer, director or promoter · active 2014–2023 · Other Technology, Biotechnology, Software / Tech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pallidus, Inc. | — | Other Technology | Series C | $129.7M | $334.2M | 2023 |
| Gemstone BioTherapeutics, LLC | — | Biotechnology | Seed | $2.3M | $31.1M | 2015 |
| Fuse Financial Technologies Inc. | — | Software / Tech | Seed | $1.9M | $19.1M | 2023 |
| Gamma3, LLC | — | Other | Pre-Seed | $750K | $17.3M | 2014 |
George Davis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside George Davis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Oros | 2 | 5 |
| James Smith | 1 | 20 |
| Geoff MacKay | 1 | 5 |
| Mark Land | 1 | 3 |
| John T. Kurtzweil | 1 | 3 |
| Cooper Rinzler | 1 | 2 |
| Xin Huang | 1 | 2 |
| Walden Rhines | 1 | 2 |
| George Rzepecki | 1 | 2 |
| Richard Clemmer | 1 | 2 |
| Glenn Sandgren | 1 | 1 |
| Georges Makhoul | 1 | 1 |
| Richard L. Clemmer | 1 | 1 |
| Walden T. Rhines | 1 | 1 |
| Sharon Gerecht | 1 | 1 |
| Cooper T. Rinzler | 1 | 1 |
| John Kurtzweil | 1 | 1 |
| David Given | 1 | 1 |
| Hap Hewes | 1 | 1 |
| Jim Heddleson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.